2016 Hematological Malignancies

Previous Page

Next Page

Page Background

PET 2 Negative-Post randomization

ABVD

N=469

AVD

N=466

CR/CRu

65%

69%

RT (N)

12

20

Deaths (N)

14

14

HL

1

7

3 yr PFS

85.4%

84.4%

3 yr OS

97.1%

97.4%

Respiratory AE (Gr 3-4)

3.6%

0.6% (p=.002)

Any non-heme AE (Gr 3-4)

31%

21% (p<0.001)

Johnson PW, et al 13th ICML; 2015; Abst 008